x

Búsqueda de un ensayo clínico

* (*) Campo obligatorio

106 Resultado(s)

Ensayo clínico en reclutamiento = Ensayo clínico en reclutamiento
; Ensayos clínico en curso = Ensayos clínico en curso 
; Financiado por un miembro del IRDiRC =

Ensayo(s) clínico(s) nacional(es)

ALEMANIA

Baden-Württemberg
HEIDELBERG

Ensayos clínico en curso 
ENDEAVOR: A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone Versus Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

ALEMANIA

Hamburg
HAMBURG

ESPAÑA

Cataluña
BADALONA

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

ILE-DE-FRANCE
PARIS

A phase IIa trial testing the efficacy of Bortezomib (Velcade) in patients with advanced Waldenström macroglobulinemia (WM2)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service d'Hématologie clinique

ITALIA

LAZIO
ROMA

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
A multicenter, randomized, double-blind, placebo controlled phase III study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma - IT
Sapienza Università di Roma - Dipartimento di Neurologia e Psichiatria
Dipartimento di Biotecnologie Cellulari ed Ematologia

ITALIA

LOMBARDIA
BRESCIA

ITALIA

TRENTINO ALTO ADIGE
BOLZANO

REINO UNIDO (EL)

Devon
PLYMOUTH

A parallel randomised phase II trial of CHOP chemotherapy with or without Bortezomib in relapsed mantle cell lymphoma
Plymouth Derriford Hospital
British National Lymphoma Institute Research Group

REINO UNIDO (EL)

Greater London
LONDON

REINO UNIDO (EL)

Greater London
LONDON

Ensayos clínico en curso 
A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

REINO UNIDO (EL)

Hampshire
SOUTHAMPTON

SUIZA

Suisse Alémanique
BASEL

Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin (Dysferlin)
Universitätsspital Basel
Department of Biomedicine

SUIZA

Suisse Alémanique
BERN

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
SAKK 36/13: Combination of ibrutinib and bortezomib followed by ibrutinib maintenance to treat patients with relapsed and refractory mantle cell lymphoma; a multicenter Phase I/II trial
University Hospital Inselspital
Universitätsklinik und Poliklinik für Medizinische Onkologie / Brust-und Tumor Zentrum der Frauenklinik

Ensayo(s) clínico(s) multinacional(es)